Skip to search formSkip to main contentSkip to account menu

FAM64A gene

Known as: RCS1, FLJ10491, FLJ10156 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A four‐gene signature predicts the efficacy of paclitaxel‐based neoadjuvant therapy in human epidermal growth factor receptor 2–negative breast cancer
Neoadjuvant chemotherapy (NAC) is the major preoperative treatment of breast cancer (BC) with negative human epidermal growth… 
2016
2016
CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells
The CATS (FAM64A) protein interacts with CALM (PICALM) and the leukemic fusion protein CALM/AF10. CATS is highly expressed in… 
2013
2013
The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS).
2006
2006
Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes.
Polygenic mouse models for obesity-induced type 2 diabetes (T2D) more accurately reflect the most common manifestations of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)